IE800321L - An antihypercholesteraemic agent, monacolin k - Google Patents

An antihypercholesteraemic agent, monacolin k

Info

Publication number
IE800321L
IE800321L IE800321A IE32180A IE800321L IE 800321 L IE800321 L IE 800321L IE 800321 A IE800321 A IE 800321A IE 32180 A IE32180 A IE 32180A IE 800321 L IE800321 L IE 800321L
Authority
IE
Ireland
Prior art keywords
substance
monacolin
acetone
c24h36o5
dichloromethane
Prior art date
Application number
IE800321A
Other versions
IE49743B1 (en
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IE800321L publication Critical patent/IE800321L/en
Publication of IE49743B1 publication Critical patent/IE49743B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Abstract

PURPOSE:To produce blood cholesterol lowering drug by cultivating a monacolin K-producing strain of the microoganism Monascus. CONSTITUTION:Monascus ruber No.1005 (FERM-P4822) strain is cultivated, and the produced physiologically active substance monacolin K is isolated. The substance monacolin K is neutral and colorless crystal. The substance has molecular formula C24H36O5(MW=404). The elemental analysis for C24H36O5:C71.56%; H8.85%; O 19.59%. The substance shows a melting point of 157-159 deg.C and an optical rotation of [alpha]D<25>=+307.6(c=1, in methanol). The substance is soluble in alcohol, acetone, ethyl acetate, chloroform and benzene; and insoluble in hexane and petroleum ether. In chromatographic studies, silica gel thin-layer chromatography employing developer consisting of dichloromethane and acetone in a ratio of dichloromethane to acetone of 4:1 shows a single spot of Rf=0.47. [JP55111790A]
IE321/80A 1979-02-20 1980-02-19 Antihypercholesteraemic agent,monacolin k,and its preparation IE49743B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54017856A JPS5925599B2 (en) 1979-02-20 1979-02-20 New physiologically active substance monacolin K and its production method

Publications (2)

Publication Number Publication Date
IE800321L true IE800321L (en) 1980-08-20
IE49743B1 IE49743B1 (en) 1985-12-11

Family

ID=11955290

Family Applications (1)

Application Number Title Priority Date Filing Date
IE321/80A IE49743B1 (en) 1979-02-20 1980-02-19 Antihypercholesteraemic agent,monacolin k,and its preparation

Country Status (27)

Country Link
JP (1) JPS5925599B2 (en)
KR (1) KR830002801B1 (en)
AT (1) AT373915B (en)
AU (1) AU532626B2 (en)
BE (1) BE881825A (en)
CA (1) CA1129794A (en)
CH (1) CH645890A5 (en)
DD (1) DD154494A5 (en)
DE (2) DE3051175C2 (en)
DK (2) DK149095C (en)
ES (1) ES8103171A1 (en)
FI (1) FI66427C (en)
FR (1) FR2449685B1 (en)
GB (1) GB2046737B (en)
HU (1) HU182069B (en)
IE (1) IE49743B1 (en)
IT (1) IT1175260B (en)
MX (1) MX6314E (en)
NL (1) NL191540C (en)
NO (1) NO153974C (en)
NZ (1) NZ192919A (en)
PH (1) PH15145A (en)
PL (1) PL124304B1 (en)
SE (1) SE453301B (en)
SG (1) SG6784G (en)
SU (2) SU1158048A3 (en)
ZA (1) ZA80962B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS5621594A (en) * 1979-07-27 1981-02-28 Sankyo Co Ltd Mb-530b carboxylic acid metal salt and its preparation
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
JPH0692381B2 (en) * 1980-03-31 1994-11-16 三共株式会社 MB-530A derivative
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
DK149080C (en) * 1980-06-06 1986-07-28 Sankyo Co METHOD FOR PREPARING ML-236B CARBOXYLIC ACID DERIVATIVES
JPS5835144A (en) * 1981-08-27 1983-03-01 Sankyo Co Ltd Mb-530b derivative and its preparation
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
CA2062023A1 (en) 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
JPH07504568A (en) * 1992-03-04 1995-05-25 藤沢薬品工業株式会社 Tetralin derivatives as HMG-CoA reductase inhibitors
NZ247617A (en) 1992-05-15 1995-07-26 Sankyo Co Octahydronaphthalene oxime derivatives and pharmaceutical compositions
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
US6812007B1 (en) * 1992-11-04 2004-11-02 Keri Vilmos Process for the isolation and purification of mevinolin
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
US6500651B1 (en) 1998-03-20 2002-12-31 Biogal Gyogyszergyar Rt. Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid
US6387258B1 (en) 2000-02-24 2002-05-14 Biogal Gyogyszergyar Rt. Method of purifying statins from a fermentation broth
TR200403001T3 (en) 2000-03-03 2005-02-21 Plus Chemical, S.A. A process for the treatment of lovastatin and simvastatin with reduced dimeric impurity levels
KR20010095780A (en) * 2000-04-12 2001-11-07 나가오카 마사시 Embryo monascus
IN192861B (en) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
CN1273608C (en) * 2001-02-09 2006-09-06 荷兰联合利华有限公司 Process for preparation of one or more statins by fermentation
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
KR20020093147A (en) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 Preventive and Dietary Supplement for adult chronic disease
KR100710500B1 (en) 2005-05-18 2007-04-24 고려대학교 산학협력단 Method for producing Monacolin K using Monascus sp
EP2373609B1 (en) 2008-12-19 2013-10-16 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
RO128803A0 (en) 2012-10-12 2013-09-30 Ion Gigel Fulga Composition for the treatment or prevention of dyslipidemias
CN110331151A (en) * 2019-04-11 2019-10-15 北京工商大学 The construction method of purple Monascus mokH gene overexpression bacterial strain
CN111297938A (en) * 2020-03-11 2020-06-19 北京康立生医药技术开发有限公司 Method for detecting lovastatin in composition for assisting in reducing blood fat

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (en) * 1974-06-07 1981-03-18
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
GR69216B (en) * 1979-06-15 1982-05-07 Merck & Co Inc

Also Published As

Publication number Publication date
NO800451L (en) 1980-08-21
DK21889D0 (en) 1989-01-18
ZA80962B (en) 1981-03-25
SU969702A1 (en) 1982-10-30
NO153974C (en) 1986-06-25
CA1129794A (en) 1982-08-17
KR830002801B1 (en) 1983-12-16
FR2449685B1 (en) 1985-06-28
NL191540C (en) 1995-09-04
NZ192919A (en) 1984-07-06
SE8001339L (en) 1980-08-21
CH645890A5 (en) 1984-10-31
DE3006216A1 (en) 1980-09-04
DK149095B (en) 1986-01-20
PH15145A (en) 1982-08-24
NL8001041A (en) 1980-08-22
ES488796A0 (en) 1981-02-16
FI66427C (en) 1984-10-10
FR2449685A1 (en) 1980-09-19
BE881825A (en) 1980-08-20
NO153974B (en) 1986-03-17
SE453301B (en) 1988-01-25
AU532626B2 (en) 1983-10-06
FI800506A (en) 1980-08-21
IT1175260B (en) 1987-07-01
DE3006216C2 (en) 1985-10-31
SU1158048A3 (en) 1985-05-23
DD154494A5 (en) 1982-03-24
DK73080A (en) 1980-08-21
ATA92980A (en) 1983-07-15
SG6784G (en) 1985-02-08
JPS55111790A (en) 1980-08-28
AT373915B (en) 1984-03-12
GB2046737A (en) 1980-11-19
DK21889A (en) 1989-01-18
PL222120A1 (en) 1980-10-20
NL191540B (en) 1995-05-01
IT8067262A0 (en) 1980-02-20
AU5567380A (en) 1980-08-28
DK149095C (en) 1986-06-16
FI66427B (en) 1984-06-29
KR830002030A (en) 1983-05-21
PL124304B1 (en) 1983-01-31
ES8103171A1 (en) 1981-02-16
HU182069B (en) 1983-12-28
GB2046737B (en) 1983-01-12
MX6314E (en) 1985-04-01
IE49743B1 (en) 1985-12-11
JPS5925599B2 (en) 1984-06-19
DE3051175C2 (en) 1989-12-21

Similar Documents

Publication Publication Date Title
IE800321L (en) An antihypercholesteraemic agent, monacolin k
CA1297030C (en) Treatment of psoriasis, ichthyosis, and acne with manoalide
JPS5632481A (en) Antibiotic b-41d, its preparation, and acaricide and anthelminthic agent and repellent containing the same as active constituent
US5459160A (en) Iridoid derivatives and the use thereof as a drug
SANKAWA et al. Antitumor activity of shikonin, alkannin and their derivatives. II. X-ray analysis of cyclo-alkannin leucoacetate, tautomerism of alkannin and cyclo-alkannin and antitumor activity of alkannin derivatives
IE45247L (en) Preparing dibenzopyranones from norpinanones
Ralph et al. Simple preparation of 8− 5-coupled diferulate
Dethoup et al. Merodrimanes and other constituents from Talaromyces thailandiasis
Bravo B et al. Trypanocidal withanolides and withanolide glycosides from Dunalia brachyacantha
Wiley et al. Erythromycin. XII. 1 The Isolation, Properties and Partial Structure of Erythromycin C
Giner et al. Nonpolar Components of the Latex of Euphorbia p eplus
De Rosa et al. A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides
Teunisson et al. Isolation and structure of a biologically reduced aflatoxin B1
Ye et al. Longimicins A− D: Novel bioactive acetogenins from Asimina longifolia (Annonaceae) and structure− activity relationships of asimicin type of Annonaceous acetogenins
Chexal et al. Gilmicolin and Mycorrhizinol, Two New Metabolites of Gilmaniella humicolaBARRON
Djerassi et al. Terpenoids. V. 1 The Isolation of Iresin, a New Sesquiterpene Lactone2
US5079377A (en) Novel androst-4-ene-3,17-dione derivatives and method for preparing same
KR880011168A (en) Process for preparing macrocyclic compound
FR2449686A1 (en) NOVEL ESTER OF ACID 1- (P-CHLOROBENZOYL) -5-METHOXY-2-METHYLINDOLE-3-ACETIQUE AND ITS PREPARATION, AS WELL AS THE MEDICINAL PRODUCT COMPRISING IT AND ITS PREPARATION
Friis et al. New epoxyubiquinones
US5244918A (en) Benzofuran derivative and pharmaceutical comprising the same as active ingredient
Chen et al. Tonkinecin, a novel bioactive annonaceous acetogenin from Uvaria tonkinesis
Gerber Phenoxazinones by oxidative dimerization of aminophenols
FR2416885A1 (en) NEW LONG-CHAIN FATTY ACID DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
GB2068964A (en) 7-oxygenated sterol 3-glycosides

Legal Events

Date Code Title Description
MK9A Patent expired